Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Towers Regulatory News (HTWS)

Share Price Information for Helios Towers (HTWS)

Share Price is delayed by 15 minutes
Get Live Data
211.20    -0.80 (-0.38%)
Bid:
211.00
Ask:
211.40
Spread: 0.40 (0.19%)
Market Cap: £2.16b
HTWS Live PriceLast checked at - London Stock Exchange

Intraday Helios Towers Share Chart

Transaction in Own Shares

11 May 2026 07:37

RNS Number : 7657D
Helios Towers PLC
11 May 2026
 

Helios Towers plc

Share Buyback Programme - Transactions in Own Securities

Helios Towers plc (the "Company") announces that in the period 5 May 2026 to 8 May 2026 it purchased a total of 139,771 of its ordinary shares of £0.01 each ("Ordinary Shares"), through Merrill Lynch International ("MLI") as detailed below:

Date of purchase

Number of Ordinary Shares purchased

Highest price paid (pence per Ordinary Share)

Lowest price paid (pence per Ordinary Share)

Volume weighted average price paid (pence per Ordinary Share)

05/05/26

67,492

198.8000

193.9000

195.8092

06/05/26

65,305

203.2000

197.6000

201.9921

07/05/26

4,345

228.0000

223.8000

226.2663

08/05/26

2,629

230.0000

229.4000

229.9369

The Company intends to cancel the purchased Ordinary Shares and does not intend to hold any of the purchased Ordinary Shares in treasury.

The purchases form part of the Company's share buyback programme as announced on 6 November 2025.

Following settlement of the above purchases and cancellation of the purchased Ordinary Shares, the Company's total number of Ordinary Shares in issue shall be 1,044,748,040 Ordinary Shares. The figure of 1,044,748,040 Ordinary Shares may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 (the Market Abuse Regulation), as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended, a detailed breakdown of individual trades made by Merrill Lynch International on behalf of the Company as part of the share buyback programme is set out below.

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

LEI number of Helios Towers plc: 213800DGC7GS4XCHCU30

Schedule of Purchases

 

Aggregate information:

Trading venue

 

Aggregated volume

Weighted average price(pence per Ordinary Share)

London Stock Exchange (LSE)

90,929

200.5432

Chi-X (CHIX)

22,957

199.8153

BATE (BATE)

20,087

199.8624

Turqoise (TRQX)

5,798

199.6011

Transaction Details:

 

Issuer name:

Helios Towers plc

ISIN:

GB00BJVQC708

Intermediary name:

Merrill Lynch International

Intermediary code:

MLILGB3LELE

Time zone:

UKT

Currency:

GBP

Individual Transactions:

 

Please see attached PDF for full list of transactions.

 http://www.rns-pdf.londonstockexchange.com/rns/7657D_1-2026-5-11.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSAKDBNABKKNPD
Date   Source Headline
30th Nov 20227:00 amRNSTotal Voting Rights
25th Nov 20227:00 amRNSUpdate on Omantel Tower Portfolio Acquisition
14th Nov 20227:00 amRNSOmantel Tower Acquisition Long-Stop Date Extension
9th Nov 20228:53 amRNSHolding(s) in Company
3rd Nov 20227:00 amRNSQ3 2022 Results
6th Oct 20227:00 amRNSNotice of Q3 2022 Results Date & Conference Call
3rd Oct 20227:00 amRNSBlock Listing Application
29th Sep 202212:03 pmRNSOmantel Tower Acquisition Long-Stop Date Extension
18th Aug 20227:00 amRNSDirectorate Change
18th Aug 20227:00 amRNSHalf-year Report
13th Jul 20227:00 amRNSNotice of H1 2022 Results Date & Conference Call
5th Jul 20227:00 amRNSOmantel Tower Acquisition Long-Stop Date Extension
21st Jun 202212:49 pmRNSDirector/PDMR Shareholding
17th Jun 202210:27 amRNSDirector/PDMR Shareholding
7th Jun 20229:57 amRNSOmantel Tower Acquisition Update
5th May 202210:30 amRNSCapital Markets Day 2022
5th May 20227:00 amRNSQ1 2022 Results
29th Apr 202212:29 pmRNSDirector/PDMR Shareholding
28th Apr 20222:58 pmRNS2022 Annual General Meeting Results
20th Apr 202212:37 pmRNSNotice of Q1 2022 Results Date and CMD
28th Mar 20222:04 pmRNS2021 Annual Report & Accounts & 2022 Notice of AGM
25th Mar 20227:00 amRNSClosing of tower acquisition in Malawi
24th Mar 20229:11 amRNSDirector Declaration
21st Mar 20225:08 pmRNS2021 Annual Report and Accounts
18th Mar 20224:41 pmRNSSecond Price Monitoring Extn
18th Mar 20224:36 pmRNSPrice Monitoring Extension
17th Mar 20227:00 amRNSFinal Results
10th Mar 20227:00 amRNSBoard Update - Director Changes
25th Feb 20227:00 amRNSAirtel Africa Tower Portfolio Transactions Update
11th Feb 20227:00 amRNSOmantel tower acquisition long-stop date extension
2nd Feb 20229:00 amRNSNotice of FY2021 Results Date & Conference Call
14th Dec 20212:12 pmRNSHolding(s) in Company
1st Dec 20215:12 pmRNSHolding(s) in Company
25th Nov 20217:00 amRNSCarbon Reduction Roadmap
3rd Nov 20217:00 amRNSClosing of tower acquisition in Madagascar
28th Oct 20217:00 amRNSQ3 2021 Results
22nd Oct 20218:25 amRNSDirector Declaration
11th Oct 20217:00 amRNSNotice of Q3 2021 Results Date & Conference Call
27th Sep 20213:33 pmRNSDirector/PDMR Shareholding
19th Aug 20217:00 amRNSUnaudited results for the 6 months ended 30 Jun 21
18th Aug 20215:00 pmRNSHelios Towers Announces CEO Transition
4th Aug 20217:00 amRNSNotice of H1 2021 Results Date & Conference Call
2nd Jul 20219:48 amRNSHolding(s) in Company
2nd Jul 20219:47 amRNSDirector/PDMR Shareholding
30th Jun 20216:11 pmRNSHolding(s) in Company
30th Jun 202111:12 amRNSTotal Voting Rights
18th Jun 20219:25 amRNSTotal Voting Rights
17th Jun 202112:46 pmRNSDirector/PDMR Shareholding
16th Jun 20217:00 amRNSResults of Placing
15th Jun 20215:06 pmRNSRetail Offer via Primary Bid

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.